Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity

NCT03785223 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT03785223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03785223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
Lead sponsor
McMaster University
Phase
Phase 4
Overall status
Completed
Start date
April 20, 2019
Completion date
October 31, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agoraphobia, attention deficit hyperactivity disorder, generalized anxiety disorder, panic disorder, social anxiety disorder